Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NCF2 |
| Upstream (Parents) |
|---|
| (<<) CD53 → NCF2 |
| (<<) ALOX5AP → NCF2 |
| (<<) SLA → NCF2 |
| Downstream (Children) |
|---|
| NCF2 → CYTIP (>>) |
| NCF2 → HMGB3L1 (>>) |
| NCF2 → C5AR1 (>>) |
| NCF2 → LSP1 (>>) |
| NCF2 → MMP8 (>>) |
| NCF2 → PIK3CG (>>) |
| NCF2 → BCL2A1 (>>) |
| NCF2 → ITGB7 (>>) |
| NCF2 → TUBA8 (>>) |
| NCF2 → TREM1 (>>) |
| NCF2 → PHACTR1 (>>) |
| NCF2 → ALOX5 (>>) |
| NCF2 → ALOX5AP (>>) |
| NCF2 → CXCR4 (>>) |
| NCF2 → ZDHHC11 (>>) |
| NCF2 → MNDA (>>) |
| NCF2 → SPTBN2 (>>) |
| NCF2 → LAIR2 (>>) |
| NCF2 → ITGAX (>>) |
| NCF2 → FGR (>>) |
| NCF2 → RUNX3 (>>) |
| NCF2 → CCL3L3///CCL3L1///CCL3 (>>) |
